Xeris Biopharma Holdings, Inc. (XERS) KPIs and segments
Close on Nov 17, 2026Market cap $3.06BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Xeris Biopharma's business
Xeris Biopharma's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product revenue, net($M) | 91.0 | 82.5 | 83.4 | 74.1 | 67.7 | 57.8 | 57 | 52.9 | 46.5 | 40.3 | 42.5 | 41.7 | |
Recorlev($M) | 56.8 | 49.8 | 45.3 | 37.0 | 31.4 | 25.5 | 22.6 | 17.7 | 13.3 | 10.6 | 9.81 | 8.10 | |
Gvoke($M) | 22.5 | 20.8 | 24.6 | 25.2 | 23.5 | 20.8 | 23.3 | 22.9 | 20.0 | 16.6 | 18.6 | 17.7 | |
Keveyis($M) | 11.7 | 11.9 | 12.8 | 11.9 | 11.5 | 11.4 | 11.1 | 12.2 | 13.1 | 13.1 | 14.1 | 15.9 | |
Royalty, contract and other revenue($M) | 1.10 | 0.67 | 2.38 | 0.32 | 3.83 | 2.32 | 3.10 | 1.41 | 1.55 | 0.38 | 1.88 | 6.62 | |
Other product revenue($M) | 0 | 0.65 | 0 | 1.31 | 0 | 0 | 0 | ||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?